- $29.18bn
- $29.07bn
- $2.27bn
- 100
- 15
- 86
- 74
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,516 | 1,681 | 1,907 | 2,066 | 2,270 |
Cost of Revenue | |||||
Gross Profit | 1,350 | 1,456 | 1,649 | 1,815 | 1,999 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,001 | 1,185 | 1,393 | 1,473 | 1,644 |
Operating Profit | 515 | 496 | 513 | 593 | 626 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 523 | 494 | 515 | 575 | 592 |
Provision for Income Taxes | |||||
Net Income After Taxes | 449 | 434 | 455 | 524 | 500 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 451 | 434 | 455 | 524 | 500 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 451 | 434 | 455 | 524 | 500 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.23 | 4.97 | 5.16 | 6.09 | 5.82 |